v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:        
Net loss $ (2,561,786) $ (10,248,486) $ (24,059,084) $ 1,229,601
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation 315,833 3,898,867 10,000
Stock-based compensation - business combination related 9,250,000 9,521,734
Amortization of debt discount 1,187 64,850 242,095 6,566
Depreciation of property and equipment 1,709 20,321 13,341
Amortization of software development costs 8,333 25,000 16,667
Gain on debt settlement, net (141,653) (1,221,635)
Finance expense 100,000 100,000
Changes in assets and liabilities:        
Accounts receivable, net and other receivables (648,568) (1,300,686) 363,405 (3,492,651)
Prepaid expenses and other current assets (46,801) (11,415) 39,330 (43,448)
Accounts payable and accrued liabilities (184,201) (286,114) (836,585) 562,946
Accrued compensation and benefits 96,248 37,673 (59,859) 345,908
Accrued interest payable 138,254 (219,320) (119,946) (20,211)
Net cash used in operating activities (2,889,834) (2,745,109) (12,086,357) (1,371,281)
Cash flows from investing activities:        
Cash acquired on business combination 34,983 34,983 2,048
Issuance of promissory notes     (439,114)
Capitalized software development costs (129,000) (70,000) (455,000) (448,000)
Cash withdrawn from Trust Account in connection with redemption 1,001,216 1,001,216
Release of Trust Account to Company’s bank account 833,324 833,324
Net cash (used in)/provided by investing activities (129,000) 1,799,523 1,414,523 (885,066)
Cash flows from financing activities:        
Proceeds from exercise of warrants 167 3,309,921 3,664,871
Redemption of common stock subject to redemption (1,001,216) (1,001,216)
Proceeds from private placement     4,780,021 1,000,000
Proceeds from capital raise     6,983,688
Proceeds from revolving line of credit     252,314
Repayments of revolving line of credit (207,850) (9,300) (315,671)
Proceeds from bank borrowings     31,954
Repayment of bank borrowings (5,114) (775,192)
Repayment of loans payable     (210,843)
Proceeds from convertible notes payable 386,500 2,376,500
Net cash (used in)/provided by financing activities (207,683) 3,173,991 15,886,279 1,689,268
Net (decrease)/increase in cash and cash equivalents (3,226,517) 2,228,405 5,214,445 (567,079)
Cash and cash equivalents, beginning of period 5,255,235 40,790 40,790 607,869
Cash and cash equivalents, end of period 2,028,718 2,269,195 5,255,235 40,790
Nonrelated Party [Member]        
Cash flows from financing activities:        
Proceeds from notes payable 513,200 513,200 390,000
Repayments of notes payable $ (20,000) (101,579)
Related Party [Member]        
Cash flows from financing activities:        
Proceeds from notes payable     15,000
Repayments of notes payable     $ (27,500)